Home › Mutual Funds › Nippon Mutual Fund › Nippon India Pharma Fund - Bonus
Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund - Bonus

Add To Compare

previously known as Reliance Pharma Bns until

502.727 (0.307%)
NAV on October 03, 2025
Category Equity:
Sector - Healthcare
Total Assets 8,357 cr
Turnover Ratio 14.27%
Expense Ratio 1.80%
Exit Load 1.00%if redeemed within
1 Months0.00%if redeemed after 1 Months
Returns
  • 1M: -2.22%
  • 1Y: -3.03%
  • 3M: -3.30%
  • 3Y: 20.81%
  • 6M: 3.78%
  • 5Y: 17.26%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since over 20 years) Kinjal Desai (Since over 7 years)
ISIN INF204K01950
Fund Family Nippon
P/E Ratio 36.11
P/B Ratio 5.78
Launch Date June 05, 2004
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
CREDIT QUALITY (%)
AAA -
AA -
A -
BBB -
BB -
B -
Below B -
Unrated -
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha -1.02
Beta 0.91
R-Squared 94.78
Info Ratio -0.72
Tracking Err 3.76
Sortino 1.571
Sharpe 0.890
Std Dev 15.220
Risk -
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
42.690 3.02% 6,162 cr 1.04% -
Sbi
SBI Healthcare Opportunities Fund Direct Growth
485.889 2.63% 3,963 cr 0.91% -
Uti
UTI Healthcare Fund-Growth Option- Direct
324.472 0.51% 1,119 cr 1.3% -
Quant
Quant Healthcare Fund Direct Growth
15.852 -9.23% 384 cr 0.8% -


Other plans of Nippon India Pharma

Data Partner
Click here to visit AMC website and
read all scheme related documents Nippon Fund